| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/10/2023 | 42.65% | Goldman Sachs | $1.15 → $1 | Maintains | Neutral |
| 11/08/2022 | 327.96% | Goldman Sachs | $3.5 → $3 | Maintains | Neutral |
| 08/17/2022 | 541.94% | UBS | $10 → $4.5 | Downgrades | Buy → Neutral |
| 08/10/2022 | 327.96% | B of A Securities | → $3 | Downgrades | Buy → Underperform |
| 08/10/2022 | 399.29% | Goldman Sachs | → $3.5 | Downgrades | Buy → Neutral |
| 07/14/2022 | 613.27% | Goldman Sachs | $9.5 → $5 | Maintains | Buy |
| 05/11/2022 | 1255.21% | Goldman Sachs | $11 → $9.5 | Maintains | Buy |
| 04/13/2022 | 1469.19% | Goldman Sachs | $17 → $11 | Maintains | Buy |
| 01/07/2022 | 2895.72% | B of A Securities | → $21 | Upgrades | Neutral → Buy |
| 06/21/2021 | 3608.99% | B of A Securities | → $26 | Initiates Coverage On | → Neutral |
| 06/21/2021 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
| 06/21/2021 | 4179.6% | JP Morgan | → $30 | Initiates Coverage On | → Overweight |
| 06/21/2021 | 4892.87% | Goldman Sachs | → $35 | Initiates Coverage On | → Buy |
What is the target price for Singular Genomics Sys (OMIC)?
The latest price target for Singular Genomics Sys (NASDAQ: OMIC) was reported by Goldman Sachs on August 10, 2023. The analyst firm set a price target for $1.00 expecting OMIC to rise to within 12 months (a possible 42.65% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Singular Genomics Sys (OMIC)?
The latest analyst rating for Singular Genomics Sys (NASDAQ: OMIC) was provided by Goldman Sachs, and Singular Genomics Sys maintained their neutral rating.
When is the next analyst rating going to be posted or updated for Singular Genomics Sys (OMIC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Singular Genomics Sys, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Singular Genomics Sys was filed on August 10, 2023 so you should expect the next rating to be made available sometime around August 10, 2024.
Is the Analyst Rating Singular Genomics Sys (OMIC) correct?
While ratings are subjective and will change, the latest Singular Genomics Sys (OMIC) rating was a maintained with a price target of $1.15 to $1.00. The current price Singular Genomics Sys (OMIC) is trading at is $0.70, which is out of the analyst's predicted range.